Heparin Sodium Injection Enoxaparin Sodium Injection Us FDA

Name: Heparin Sodium Injection Enoxaparin Sodium Injection Us FDA
Brand: Shanghai Himed Pharmaceutical Co., Ltd.
SKU: 1939920265

Shanghai, ChinaShanghai Himed Pharmaceutical Co., Ltd.

US$0.15-0.20

50,000 Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For external use

Model NO.

25000 U. I. /5ml 5000U. I/5ml 0.2ml:2000IU 0.4ml:

Suitable for

Adult

State

Liquid

Shape

Liquid

Type

Biological Products

Pharmaceutical Technology

Chemical Synthesis

Usage

Human

HS

3004

Capacity

10000000

Transport

by Sea or Air

Transport Package

Carton

Specification

25000 U. I. /5ml 5000U. I/5ml 0.2ml:2000IU 0.4ml:

Trademark

HIMED or OEM

Origin

China

HS Code

3004909099

Production Capacity

100, 000, 000 Per Year

Company profile

Shanghai Himed Pharmaceutical Co., Ltd.

Shanghai, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2016-06-08Nearest Port: shanghaiAverage Response Time: ≤3.22hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, EXW, CFR, CIF

AI-Powered supplier vetting

SummaryShanghai Himed Pharmaceutical Co., Ltd. is a China-based trading company and manufacturer specializing in pharmaceuticals and medical supplies. The company holds ISO 9001 and GMP certifications, indicating a commitment to quality management. With a focus on international markets, they export a significant portion of their products globally, operating more than ten production lines. However, the company's financial credibility and after-sales service capabilities require further evaluation due to limited data.

Supplier typeThe supplier is both a trading company and a manufacturer/factory, indicating they are involved in both the production and distribution of goods.

CertificationsThe supplier holds ISO 9001 and GMP certifications, demonstrating adherence to quality management and good manufacturing practices.

Production capacityThe supplier operates over ten production lines with an annual output between US$10 Million to US$50 Million, indicating substantial production capability.

Customization capabilityThe supplier can provide pharmaceuticals under their own brands as well as customer brands, indicating some level of customization capability.

Client casesThere is evidence of at least one customer case involving a buyer in Cameroon.